CSAM (Norge)

Current investments - CSAM

CSAM is the leading provider of niche eHealth solutions in the Nordics. The company’s software solutions enable healthcare providers to access relevant clinical information at the point of care. CSAM’s portfolio of products includes the leading maternity software, blood management software, medical imaging software (non-radiology), oncology medication software, connected healthcare software and emergency and acute software in the Nordics. Headquartered in Oslo, Norway, CSAM has 140 employees and nine offices operating in five countries, including a fully-owned software engineering subsidiary in the Philippines.

Investment year: 2014
Turnover: SEK 175m
Fund: Priveq Investment IV
Ownership: 38%
CEO: Sverre Flatby
Phone: +47 22 94 15 90
Members of the Board:
Ansgar Gabrielsen (Chairman of the Board), Kjellrun Borgmo (Employee Representative), Mats Larson, Mats Hjerpe, Louise Nilsson
Priveq team:
Louise Nilsson, Mats Hjerpe, Senai Ayob

Related posts

CSAM announces deal to acquire KIBI

CSAM announces that it has entered into an agreement to acquire KIBI, a medical diagnostics and documentation company with offices …

Read more »

CSAM announces deal to acquire Arcid AS

CSAM has announced that it has signed an agreement to acquire Arcid AS, a Norwegian eHealth Company that focuses on …

Read more »

CSAM Health acquires Paratus Emergency Response Business

CSAM Health acquires Paratus Emergency Response Business from Saab and the acquisition will strengthen CSAM’s position in the emergency and …

Read more »

CSAM Health AS acquires Databyrån AB

CSAM Health AS has acquired Databyrån AB, makers of ProSang – an advanced Laboratory Information Management System that simplifies the …

Read more »

CSAM Health acquires Mawell eHealth Systems

As part of its continued program of growth and expansion in the healthcare sector, CSAM Health has acquired Stockholm based …

Read more »

CSAM Health has acquired AMIS AS

CSAM is entering the acute medicine and emergency area and has acquired AMIS AS. CSAM broadens its product range and …
Read more »

Priveq invests in CSAM’s growth

Priveq Investment Fund IV (”Priveq Investment”) will, through the holding company CSAM Invest AS, inject capital in CSAM Health AS …
Read more »

For further information, please contact

Louise Nilsson

Partner & CEO

Phone: +46 8 459 67 63
Mobile: +46 70 950 95 50
Read more »

Louise Nilsson

Partner & CEO

Louise Nilsson is Partner and CEO. In addition to leading and developing Priveq, she is responsible for sourcing new investment opportunities, in which Priveq will contribute with growth and value creation as well as implement growth strategies in cooperation with other owners, the board and management.

Since Louise joined Priveq in 1998, she has, among others, been responsible for the ownership in Carmel Pharma, Hemtex, Swedish Orphan International and Vårdapoteket. She is currently a Director of the Boards in 21 Grams, CSAM Health, Metenova, Plint and Ports Group.

Prior to Priveq, Louise worked as chartered accountant for ÖhrlingsCoopers & Lybrand (current PwC) for nine years, with responsibility for small and medium-sized owner-led companies.

Louise holds a B.Sc. in Business Administration from Luleå University.